Yanxia Li
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Glycosylation and Glycoproteins Research
- RNA modifications and cancer
Papers in
-
- Circular RNAs in diseases 4
- Genomics, phytochemicals, and oxidative stress 3
- CRISPR and Genetic Engineering 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Co-authors
- Shijie Yu (3 shared papers)Lei Shen (3 shared papers)Qianshan Ding (2 shared papers)Honggang Yu (2 shared papers)Ganggang Mu (2 shared papers)Yun‐Bo Shi (1 shared paper)Lingli Zhang (1 shared paper)Shanshan Wang (1 shared paper)
- Journals
- International Journal of Oncology (2 papers)International Journal of Biological Macromolecules (1 paper)Nature Neuroscience (1 paper)Journal of Inflammation (1 paper)Tumor Biology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yanxia Li
24 papers receiving 458 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 106
- Molecular Biology 291
- Pharmacology 32
- Immunology 70
- Oncology 71
Countries citing papers authored by Yanxia Li
This map shows the geographic impact of Yanxia Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanxia Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanxia Li more than expected).
Fields of papers citing papers by Yanxia Li
This network shows the impact of papers produced by Yanxia Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanxia Li. The network helps show where Yanxia Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanxia Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 78 | |
| 2 | 2009 | 59 | |
| 3 | 2017 | 59 | |
| 4 | 2018 | 43 | |
| 5 | 2019 | 35 | |
| 6 | 2022 | 23 | |
| 7 | 2019 | 19 | |
| 8 | 2016 | 17 | |
| 9 | 2018 | 17 | |
| 10 | 2014 | 15 | |
| 11 | 2017 | 14 | |
| 12 | 2021 | 14 | |
| 13 | 2018 | 12 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2017 | 8 | |
| 17 | 2013 | 6 | |
| 18 | 2004 | 5 | |
| 19 | 2019 | 5 | |
| 20 | 2015 | 5 |
About Yanxia Li
Yanxia Li is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 25 papers that have together received 463 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Gastric Cancer Management and Outcomes (3 papers), CRISPR and Genetic Engineering (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers) and Trace Elements in Health (2 papers). The work is most often cited by research in Cancer Research (106 citations), Molecular Biology (291 citations), Pharmacology (32 citations), Immunology (70 citations) and Oncology (71 citations). Yanxia Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shijie Yu, Lei Shen, Qianshan Ding, Honggang Yu, Ganggang Mu, Yun‐Bo Shi, Lingli Zhang, Shanshan Wang, Zufeng Ding and Yan Sun. Their work appears in journals such as International Journal of Oncology, International Journal of Biological Macromolecules, Nature Neuroscience, Journal of Inflammation and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.